XML 21 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Revenues $ 2,057 $ 2,576 $ 5,161 $ 5,225    
Cost of Revenues 390 856 1,180 1,653    
Gross Profit 1,667 1,720 3,981 3,572    
Operating Expenses            
Research and development 2,051 2,482 4,033 4,576    
Sales and marketing 1,241 754 2,357 1,924    
General and administrative 4,236 5,294 9,850 12,658    
Acquisition-related costs 523 137 687 252    
Transaction costs 43 1,443    
Impairment of goodwill 2,030 2,030    
Amortization of intangibles 230 396 450 743    
Total Operating Expenses 8,324 11,093 18,820 22,183    
Loss from Operations (6,657) (9,373) (14,839) (18,611)    
Other Income (Expense)            
Interest (expense)/income, net (1,756) 168 (3,481) 169    
Loss on exchange of debt for equity         $ (30)
Benefit for valuation allowance on related party loan – held for sale         7,345
Other income/(expense), net 1,183 15 1,212 (28)    
Gain on related party loan – held for sale         49,817
Unrealized gain/(loss) on equity securities (92) 247 (58) (1,256)    
Total Other (Expense) Income (665) 430 (2,327) (1,115)    
Net Loss from Continuing Operations, before tax (7,322) (8,943) (17,166) (19,726)    
Income tax benefit/(expense) (7) (22) (2,485) (22)    
Net Loss from Continuing Operations (7,329) (8,965) (19,651) (19,748)    
Loss from Discontinued Operations, Net of Tax (11,365) (4,856) (12,139)    
Net Loss (7,329) (20,330) (24,507) (31,887) (66,304) (70,130)
Net Loss Attributable to Non-controlling Interest (363) (458) (667) (804)    
Net Loss Attributable to Stockholders of Inpixon (6,966) (19,872) (23,840) (31,083)    
Net Loss Attributable to Common Stockholders $ (6,966) $ (24,857) $ (23,840) $ (42,219)    
Net Loss Per Share – Basic and Diluted            
Continuing Operations Basic (in Dollars per share) $ (0.19) $ (6.99) $ (0.92) $ (14.9)    
Discontinued Operations Basic (in Dollars per share) (5.88) (0.24) (6.01)    
Net Loss Per Share – Basic (in Dollars per share) $ (0.19) $ (12.87) $ (1.16) $ (20.91)    
Weighted Average Shares Outstanding            
Weighted Average Shares Outstanding Basic (in Shares) 37,442,387 1,931,535 20,600,208 2,018,295    
Series 7 Preferred Stock            
Other Income (Expense)            
Accretion of Series $ (4,555)    
Series 8 Preferred Stock            
Other Income (Expense)            
Accretion of Series (6,237) (6,785)    
Deemed dividend for the modification related to Series 8 Preferred Stock (2,627)    
Deemed contribution for the modification related to Warrants issued in connection with Series 8 Preferred Stock 1,469    
Amortization premium-modification related to Series 8 Preferred Stock $ 1,252 $ 1,362    
Previously Reported            
Revenues         10,948 9,627
Cost of Revenues         3,425 2,728
Gross Profit         7,523 6,899
Operating Expenses            
Research and development         8,338 7,417
Sales and marketing         3,876 3,498
General and administrative         15,520 20,871
Acquisition-related costs         410 620
Impairment of goodwill and intangibles         6,659 2,893
Amortization of intangibles         1,526 1,421
Total Operating Expenses         36,329 36,720
Loss from Operations         (28,806) (29,821)
Other Income (Expense)            
Interest (expense)/income, net         (677) 1,182
Loss on exchange of debt for equity         (30)
Benefit for valuation allowance on related party loan – held for sale         7,345
Other income/(expense), net         693 (47)
Gain on related party loan – held for sale         49,817
Unrealized gain/(loss) on equity securities         (7,904) (57,067)
Unrealized loss on equity method investment         (1,784)
Total Other (Expense) Income         (9,672) 1,200
Net Loss from Continuing Operations, before tax         (38,478) (28,621)
Income tax benefit/(expense)         249 (3,789)
Net Loss from Continuing Operations         (38,229) (32,410)
Loss from Discontinued Operations, Net of Tax         (28,075) (37,720)
Net Loss         (66,304) (70,130)
Net Loss Attributable to Non-controlling Interest         (2,910) (975)
Net Loss Attributable to Stockholders of Inpixon         (63,394) (69,155)
Net Loss Attributable to Common Stockholders         $ (79,570) $ (77,316)
Net Loss Per Share – Basic and Diluted            
Continuing Operations Basic (in Dollars per share)         $ (22.08) $ (26.21)
Discontinued Operations Basic (in Dollars per share)         (12.04) (24.97)
Net Loss Per Share – Basic (in Dollars per share)         $ (34.12) $ (51.18)
Weighted Average Shares Outstanding            
Weighted Average Shares Outstanding Basic (in Shares)         2,332,041 1,510,678
Previously Reported | Series 7 Preferred Stock            
Other Income (Expense)            
Accretion of Series         $ (4,555) $ (8,161)
Previously Reported | Series 8 Preferred Stock            
Other Income (Expense)            
Accretion of Series         (13,090)
Deemed dividend for the modification related to Series 8 Preferred Stock         (2,627)
Deemed contribution for the modification related to Warrants issued in connection with Series 8 Preferred Stock         1,469
Amortization premium-modification related to Series 8 Preferred Stock         $ 2,627